Mubadala Investment Co PJSC

Insider Reports History

Location
Abu Dhabi, United Arab Emirates
Signature
MUBADALA INVESTMENT COMPANY PJSC, Name: /s/ Matthew Ryan, Title: Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mubadala Investment Co PJSC:

Company Role Class Num Shares Value Price $ Report Date Ownership
MidCap Apollo Institutional Private Lending 10%+ Owner Common shares of beneficial interest 14,561,742 $351,811,686 $24.16 29 Jul 2025 Indirect
RECURSION PHARMACEUTICALS, INC. 10%+ Owner Class A Common Stock 12,985,927 $137,333,970 $10.58 02 Mar 2023 Indirect
Endeavor Group Holdings, Inc. Other* Class A Common Stock 0 $0 $27.50 24 Mar 2025 Indirect
Blue Owl Technology Finance Corp. II Former 10% Owner Common Stock 0 24 Mar 2025 Indirect

Insider Reports Filed by Mubadala Investment Co PJSC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017025101063-mubadala-investment-co-pjsc-2025-07-29 MidCap Apollo Institutional Private Lending 29 Jul 2025 1 +$18,683,604 4 10%+ Owner 31 Jul 2025, 19:12
/report/000095017025046148-mubadala-investment-co-pjsc-2025-03-24 Blue Owl Technology Finance Corp. II 24 Mar 2025 1 $0 4 Former 10% Owner 27 Mar 2025, 16:37
/report/000095017025045701-mubadala-investment-co-pjsc-2025-03-24 Endeavor Group Holdings, Inc. 24 Mar 2025 1 -$61,400,542 4 Other* 27 Mar 2025, 06:18
/report/000095017025046136-mubadala-investment-co-pjsc-2025-03-21 Blue Owl Technology Finance Corp. II 21 Mar 2025 0 $0 3 Former 10% Owner 27 Mar 2025, 16:30
/report/000095017025006719-mubadala-investment-co-pjsc-2025-01-15 Blue Owl Technology Finance Corp. II 15 Jan 2025 0 $0 3 10%+ Owner 17 Jan 2025, 16:15
/report/000095017025114223-mubadala-investment-co-pjsc-2024-06-14 MidCap Apollo Institutional Private Lending 14 Jun 2024 1 +$43,261,453 4 10%+ Owner 11 Sep 2025, 16:10
/report/000199937124006063-mubadala-investment-co-pjsc-2024-05-14 Middle Market Apollo Institutional Private Lending 14 May 2024 0 $0 3 10%+ Owner 14 May 2024, 16:26
/report/000095017224000182-mubadala-investment-co-pjsc-2024-04-02 Endeavor Group Holdings, Inc. 02 Apr 2024 0 $0 3 Other* 09 Apr 2024, 15:15
RXRX RECURSION PHARMACEUTICALS, INC. 02 Mar 2023 1 +$522,354 4 10%+ Owner 03 Mar 2023, 15:09
RXRX RECURSION PHARMACEUTICALS, INC. 01 Mar 2023 1 +$388,082 4 10%+ Owner 02 Mar 2023, 15:05
RXRX RECURSION PHARMACEUTICALS, INC. 28 Feb 2023 1 +$6,496 4 10%+ Owner 01 Mar 2023, 15:06
RXRX RECURSION PHARMACEUTICALS, INC. 27 Feb 2023 1 +$403,725 4 10%+ Owner 28 Feb 2023, 15:14
RXRX RECURSION PHARMACEUTICALS, INC. 24 Feb 2023 1 +$833,552 4 10%+ Owner 27 Feb 2023, 15:06
RXRX RECURSION PHARMACEUTICALS, INC. 23 Feb 2023 1 +$403,792 4 10%+ Owner 24 Feb 2023, 15:08
RXRX RECURSION PHARMACEUTICALS, INC. 22 Feb 2023 1 +$399,016 4 10%+ Owner 23 Feb 2023, 15:26
RXRX RECURSION PHARMACEUTICALS, INC. 21 Feb 2023 1 +$731,126 4 10%+ Owner 22 Feb 2023, 15:07
RXRX RECURSION PHARMACEUTICALS, INC. 17 Feb 2023 1 +$488,986 4 10%+ Owner 21 Feb 2023, 15:07
RXRX RECURSION PHARMACEUTICALS, INC. 16 Feb 2023 1 +$337,043 4 10%+ Owner 17 Feb 2023, 16:27
RXRX RECURSION PHARMACEUTICALS, INC. 14 Feb 2023 1 +$50,060 4 10%+ Owner 15 Feb 2023, 15:06
RXRX RECURSION PHARMACEUTICALS, INC. 13 Feb 2023 1 +$258,837 4 10%+ Owner 14 Feb 2023, 15:10
RXRX RECURSION PHARMACEUTICALS, INC. 10 Feb 2023 1 +$87,808 4 10%+ Owner 13 Feb 2023, 15:41
RXRX RECURSION PHARMACEUTICALS, INC. 01 Feb 2023 1 +$4,782 4 10%+ Owner 02 Feb 2023, 15:07
RXRX RECURSION PHARMACEUTICALS, INC. 26 Jan 2023 1 +$63,006 4 10%+ Owner 27 Jan 2023, 15:27
RXRX RECURSION PHARMACEUTICALS, INC. 25 Jan 2023 1 +$193,267 4 10%+ Owner 26 Jan 2023, 15:11
RXRX RECURSION PHARMACEUTICALS, INC. 23 Dec 2022 11 +$7,725,857 4 10%+ Owner 13 Jan 2023, 15:19
RXRX RECURSION PHARMACEUTICALS, INC. 27 Oct 2022 1 +$24,999,996 4 10%+ Owner 31 Oct 2022, 16:08